Top Story

Hospital type, patient age influence treatment of newly diagnosed myelodysplastic syndrome

March 6, 2015

Patients treated for recently diagnosed myelodysplastic syndrome at major academic institutions received more aggressive treatment than those treated at community hospitals, according to the results of a population-based prospective study.

Younger patients also received more aggressive treatment plans, results showed.

In the Journals

Mohs micrographic surgery may effectively treat rare hidradenocarcinoma

March 5, 2015
Mohs micrographic surgery was an effective long-term treatment for patients with hidradenocarcinoma, according to study results.Researchers retrospectively evaluated the…
In the Journals

Patient characteristics linked to degree of family involvement in treatment decisions

March 5, 2015
A majority of patients recently diagnosed with lung or colorectal cancers chose to include family members in treatment-related decisions, according to study…
In the Journals

ADT increases risk for cardiovascular disease in men with prostate cancer

March 5, 2015
Patients with prostate cancer who received androgen-deprivation therapy demonstrated an increased risk for cardiovascular disease, according to study results.Men with a…
Guido Marcucci, MD Institution Notes

Physician-researcher joins City of Hope

March 5, 2015
Guido Marcucci, MD, a renowned physician and researcher, has accepted a leadership appointment at City of Hope’s new Hematologic Malignancies and Stem Cell…
More News Headlines »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »